4th Joint Transnational Call (JTC 2017)

Basic Information

Network TRANSCAN-2
Website https://www.transcanfp7.eu/index.php/calls/fourth-joint-transnational-call-jtc-2017.html
Aim of the joint call Transnational research on Rare Cancers The challenges related to research and treatment in rare cancers, are intimately tightened to the low incidence of any single clinical-pathological entity currently listed among these cancers. Aim 1: Design and conduct of translational research studies exploiting/combining resources from current clinical trials, bio-repositories and epidemiology-type resources. Aim 2: Development and exploitation of translational research platforms (e.g., patient derived xenograft models/organoids/tissue collections) to study drug responses/resistance and toxicity, and perform drug screens or repurpose approved anticancer drugs. AIM 3: Implementation of precision biomarkers for better stratification of the clinical cohorts.
Type of joint call Two Stages - Call with pre-proposals and full proposals submissions
Launch date 05/12/2017
Deadline Pre-Proposal 06/02/2018 Submitted proposal: 92
Deadline Full-Proposal 30/05/2018 Submitted proposal: 38
Evaluation End Date 01/10/2018 Successful proposal: n/a Proposals funded: 12
Is call co-funded? No
Call follow up funding n/a
Call reasons n/a
Research fields
  • Health
Type of research n/a
Target groups
  • Higher Education Institutions (HEIs)
  • Public Research Organisations (PROs)
  • SME (Small and Medium Enterprises)
Participating networks n/a

Organisations Participating

Country Organisation
Austria Austrian Science Fund (FWF)
Belgium National Fund for Scientific Research (FNRS)
Belgium Research Foundation Flanders (FWO)
Estonia Estonian Science Foundation (ETAG)
France ARC French foundation for Cancer Research (ARC-France)
France National Cancer Institute (INCa)
Germany Federal Ministry of Education and Research (BMBF)
Greece General Secretariat for Research and Technology (GSRT)
Israel Medical Research Administration Chief Scientist Office Israeli Ministriy of Health (CSO-MOH)
Italy Alliance Against Cancer (ACC)
Italy Lombardy Foundation for Biomedical Research (FRRB)
Italy Ministry of Health (MOH/MDS)
Latvia State Education Development Agency (VIAA)
Luxembourg National Fund for Research (FNR)
Netherlands Dutch Cancer Society (KWF)
Poland National Centre for Research and Development (NCBiR)
Portugal Foundation for Science and Technology (FCT)
Slovakia Slovak Academy of Science (SAS/SAV)
Spain Foundation for Asturias Promotion of Applied Scientific Research and Technology (FICYT)
Spain Institute of Health Carlos III (ISCIII)
Spain Spanish Association Against Cancer Scientific Foundation (AECC FC)
Taiwan National Science and Technology Council / Ministry of Science and Technology (NSTC / MoST Taiwan)
Türkiye The Scientific and Technological Research Council of Turkey (TUBITAK)

Funded Projects

Acronym Title Start End No. partners
BRCAddict Harnessing BRCAness as a therapeutic target in high-risk ped... 01/04/2019 7
ERANET-PLL Implementation of (epi)genetic and metabolic networks in the... 01/04/2019 5
Euro MDS An integrated european platform to conduct translational stu... 01/04/2019 4
EuroTCLym Translational Research in Peripheral T-Cell Lymphomas: from ... 01/04/2019 5
LIQUIDHOPE Advancing Liquid Biopsies for Monitoring and Personalized Tr... 01/04/2019 6
MOLCARUTUC Comprehensive genomic characterization of upper urinary trac... 01/04/2019 4
NExT Establishing an algorithm for the early diagnosis and follow... 01/04/2019 6
PMTR-pNET Predictive models of therapy response in pancreatic neuroend... 01/04/2019 4
PREDICt Profiling radioREsistant Differentiated thyroId Cancer: gene... 01/04/2019 4
Quant-ALL Automated, absolute quantification of MRD in ALL patients by... 01/04/2019 5
ROCSANbio Anti-PD1 and Niraparib (PARPi) combination therapy in gynae ... 01/04/2019 4
TOPMESO A TranslatiOnal Platform for de-orphaning malignant pleural ... 01/04/2019 3